Moffitt logo

Clinical Trials Search

Clinical Trial 18999

Cancer Type: Thoracic
Study Type: Other
NCT#:

Phase: N/A
Prinicipal Investigator:

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

Early Detection of Cancer Progression: Leveraging Team Science

Summary

The purpose of this study is to identify patterns of patient-reported outcomes (PROs) that are predictors of cancer progression, explore the relationship between tumor size and PROs, and develop software to collect PROs from patients remotely via the Internet. Investigators plan to use this information to evaluate whether PROs may be used as an early indicator of cancer progression in the future. Investigators will prospectively recruit 50 lung cancer patients to participate in this study.

Objective

Aim 1: To identify patterns of patient-reported symptoms that are early indicators of lung cancer progression. Aim 2: To explore the minimum increase in lung tumor volume detectable by patient-reported symptoms. Aim 3: To develop software to collect patient-reported symptom data between clinic visits.

Treatments

Therapies

Medications

Inclusion Criteria

  • Diagnosed with Stage IV Non-small Cell Lung Cancer (NSCLC)
  • Have radiographically assessable disease in the lung at baseline
  • Starting chemotherapy with an immune checkpoint inhibitor (i.e., PD1 or PD-L1)
  • Able to speak and read English
  • Have Internet access
  • Able to provide informed consent

  • If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.